Vice President, Business Development at Vir Biotechnology

San Francisco, California, United States

Vir Biotechnology Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Broad domain knowledge in the clinical sciences
  • Experienced senior executive with deep transactions experience
  • Scientific aptitude
  • Very strong writer and presenter
  • Strong people skills
  • Proven ability to develop high-performing teams and foster industry collaborations
  • Maintain the highest standards of compliance and excellence
  • Located in San Francisco with requirement to be onsite at least four days per week

Responsibilities

  • Independently spearhead global business development activities consistent with Vir Bio's overall internal and external innovation strategies set by the CEO, executive management team, and board of directors
  • Working closely with CMO, CSO, CBO, and other executives, lead global search and evaluation efforts to source opportunities that complement Vir Bio’s pipeline and platforms
  • Lead out-licensing initiatives to identify potential partners for certain Vir Bio assets or platforms
  • Run partnership discussion processes including direct ownership and oversight of due diligence, drafting and negotiating term sheets, working closely with legal team on negotiating collaboration agreements, and collecting feedback from various internal stakeholders
  • Lead, guide and direct teams responsible for organizing and completing extensive due diligence involving cross-functional teams of several internal and external experts (scientific, clinical, manufacturing, regulatory, marketing, financial, legal, IP)
  • Create thoughtful negotiating strategies and, with internal and external legal teams (and in some cases with investment bankers), lead face-to-face negotiations with counterparties—including by listening and doing creative problem solving
  • Working closely with Vir Bio’s finance team and external experts, including investment bankers, oversee the creation and evolution of financial models that inform the valuation of external opportunities
  • Create strategic and compelling slide decks of the highest consistency and quality and use them in presenting opportunities to the CEO, executive management team, and board of directors
  • Work closely with strategy, competitive intelligence, and alliance management leadership and teams

Skills

Key technologies and capabilities for this role

Business DevelopmentStrategic PartnershipsDeal NegotiationDue DiligenceTerm SheetsScientific AptitudeTeam LeadershipIndustry CollaborationsPresentation SkillsWriting

Questions & Answers

Common questions about this position

Is this role remote or does it require office presence?

This role is located in San Francisco at the corporate office with a requirement to be onsite at least four days per week.

What are the key responsibilities of the Vice President, Business Development?

The role involves spearheading global business development activities, leading search and evaluation efforts with executives, managing out-licensing initiatives, running partnership processes including due diligence and negotiations, and leading teams.

What skills and experience are required for this position?

Candidates need broad domain knowledge in clinical sciences, deep transactions experience, strong writing and presentation skills, scientific aptitude, strong people skills, proven ability to develop high-performing teams, and foster industry collaborations while maintaining compliance.

What is the company culture like at Vir Biotechnology?

Vir Biotechnology is committed to creating a company where everyone feels supported and encouraged to give their best, believing that the success of colleagues drives the success of the mission.

Who does this role report to and who will I collaborate with?

The role reports directly to the Chief Business Officer (CBO) and involves close collaboration with the CMO, CSO, CBO, other executives, legal team, and internal stakeholders.

Vir Biotechnology

Develops monoclonal antibodies for infectious diseases

About Vir Biotechnology

Vir Biotechnology develops treatments that leverage the immune system to combat infectious diseases. The company uses a proprietary monoclonal antibody platform combined with machine learning to create a database of human antibodies, which aids in developing effective medicines. Their pipeline includes candidates for hepatitis B, hepatitis delta, HIV, and various viruses like influenza and COVID-19. Vir stands out by collaborating with industry leaders and organizations to accelerate scientific advancements, with the goal of transforming lives through innovative therapies.

San Francisco, CaliforniaHeadquarters
2016Year Founded
$640.6MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Comprehensive healthcare coverage
Employer matched 401(k)
Employee stock purchase plan
Childcare assistance
Tuition reimbursement

Risks

Leadership instability due to key executive resignations may disrupt operations.
Job cuts and facility closures indicate potential financial strain.
Struggles to diversify beyond COVID-19 antibody success may impact revenue growth.

Differentiation

Vir Biotechnology uses AI-enhanced capabilities for monoclonal antibody development.
The company focuses on immune system manipulation for targeted therapies.
Vir's pipeline includes a potential functional cure for chronic hepatitis B.

Upsides

Increased interest in AI-driven drug discovery benefits Vir's AI capabilities.
The rise of personalized medicine aligns with Vir's monoclonal antibody focus.
Global pandemic preparedness funding supports Vir's broad-spectrum antiviral therapies.

Land your dream remote job 3x faster with AI